Furthermore, given that IL-17A was able to restore CD8+ T cell dysfunction in treated hosts, targeting the IL-17R pathway not only can help to control viral infections but also can help to fight against other microbes and, eventually, tumors. The gene discussed is IL17A; the disease is viral infectious disease.